FDA unlikely to rule on Merck's COVID pill before December

10/14/2021 | by | Uncategorized

The U.S. Food and Drug Administration will ask its outside experts to review Merck’s pill to treat COVID-19 at a meeting in late November
Source: Test feed

Leave a Comment

Your email address will not be published.

*
*
*